Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study. | MicrobiomeTrials
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-11-24Est. Completion: 2025-12-05
Enrollment target: 46 participants
Locations
Axis Clinicals Latina, S.A. de C.V., Mexico City, Mexico City, Mexico
Other microbiome trials you might be interested in